Drug Profile
SDGX 02
Alternative Names: SDGX-02Latest Information Update: 28 May 2018
Price :
$50
*
At a glance
- Originator Sideromics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetic foot ulcer; Wounds
Most Recent Events
- 28 May 2018 No recent reports of development identified for research development in Diabetic-foot-ulcer in USA (Topical, Gel)
- 28 May 2018 No recent reports of development identified for research development in Wounds in USA (Topical, Gel)
- 11 Apr 2014 Early research in Diabetic foot ulcer in USA (Topical)